High Impact (Breakthrough) Medicines for All
We strive to discover breakthrough medicines which would have a high impact on health care. We leverage resources and expertise worldwide and combine them with our unique perspectives to solve challenging medical problems. In all projects, we seek highly competitive advantages to differentiate from the competition. Our lead programs are the world’s first highly potent and selective dual TYK2/JAK1 inhibitors which can also effectively cross the blood-brain barrier. Subsequently, we have built a world-leading pipeline on neuroinflammation to tackle challenging neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
News
Learn more about the latest news on innovative drug development!
June 12,2023
Therapy with an investigative JAK1/TYK2 inhibitor led to remission in one-third of participants with difficult-to-treat rheumatoid arthritis (RA).
